Search results for: Value, Affordability, and Decision Making
Filter search results
Value Frameworks: Value in Health Special Issue
29 March 2018
…Task Force. Paper 2 provides an overview of value and perspective and explores the relationship between these and the context of decision making. Defining value is crucial, as different interpretations…
Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
24 September 2025
…and HTA. Formulary inclusion is a key determinant of access. Institutional and hospital-level Pharmacy and Therapeutics (P&T) committees review new products, with decisions often influenced by key opinion leader (KOL)…
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
20 October 2025
…health, but also for how value is generated and distributed across the wider NHS and the economy. This includes increased productivity, reduced absenteeism, and enhanced quality of life for patients…
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
…and projecting public health: Spectrum value: Enables use of narrow-spectrum antibiotics by identifying specific pathogens and resistance patterns. Transmission value: Reduces the spread of infectious and resistant pathogens through earlier detection and…
HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making
2 May 2017
…can be defined, measured and factored into decisions on access and coverage. Next, the paper looks at how budget impact and affordability can be defined and measured: we explain how…
Analysing Global Immunisation Expenditure
15 April 2025
…(such as COVID-19, pneumococcal and herpes zoster) and adolescent programmes (such as meningococcal). Data gaps hinder effective policy-making and monitoring Data on immunisation spending by age group and programme is…
Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?
14 April 2021
A new paper explores the equivalence of Multi-Criteria Decision Analysis and Augmented Cost-Effectiveness Analysis in adding elements of value to QALY-based cost-effectiveness decision making. It finds that they are equivalent…
Altering the trajectory of HIV in Europe
22 May 2025
…language, and are targeted at both general populations and healthcare professionals, have the potential to educate and reduce prejudice and stigma. Diversifying treatment options: PrEP and antiretroviral therapy (ART) are…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
…approval, and flexible reimbursement and HTA models, such as risk-sharing agreements and reassessment, are underutilised. The upcoming Joint Clinical Assessment (JCA) process may support alignment, but its uptake and impact…